France at a glance
- Population
- 68.7 million 2025
- Life expectancy at birth
- 83.0 years, 2024
- People aged 65 and over
- 22.5 % of people, 2025
- Health spending per person
- 5,327 US$ per person, 2024
- Doctors
- 3.28 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
France Omega-3 Supplements Market Industry Trends and Forecast to 2034: Segmented by (Source, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$123.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $176.8 Mn | — | — |
| 2025 (base) | $187.0 Mn | +$10.3 Mn | — |
| 2026 (forecast) | $197.9 Mn | +$10.8 Mn | +5.8% |
| 2027 (forecast) | $209.4 Mn | +$11.5 Mn | +11.9% |
| 2028 (forecast) | $221.5 Mn | +$12.1 Mn | +18.4% |
| 2029 (forecast) | $234.4 Mn | +$12.8 Mn | +25.3% |
| 2030 (forecast) | $248.0 Mn | +$13.6 Mn | +32.6% |
| 2031 (forecast) | $262.3 Mn | +$14.4 Mn | +40.3% |
| 2032 (forecast) | $277.6 Mn | +$15.2 Mn | +48.4% |
| 2033 (forecast) | $293.7 Mn | +$16.1 Mn | +57% |
| 2034 (forecast) | $310.7 Mn | +$17.0 Mn | +66.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $187.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $310.7 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Source, form and distribution channel (see all) |
| Key players | Nordic Naturals, DSM-Firmenich, Aker BioMarine, Pharmavite LLC, Carlson Labs (see all) |
| Regulator in France | ANSM and DGCCRF and ANSESSource: ANSM, French medicines agency. Checked 14 Nov 2026.Source: ANSES. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Omega-3 supplements provide EPA and DHA fatty acids from fish, krill or algae, for heart, brain and eye health.
Key segments of the omega-3 Supplements market include source (Fish Oil, Krill Oil and Algal Oil) and form (Softgels, Liquids and Gummies).
Growing interest in prevention, social media trends, ageing consumers, sports nutrition going mainstream and easy online shopping are driving the omega-3 Supplements market.
Personalised nutrition, clinically tested ingredients and new formats such as gummies and drinks give the omega-3 Supplements market strong room to grow.
Mixed scientific evidence, quality and safety concerns, strict health-claim rules and price competition hold back the omega-3 Supplements market.
The omega-3 Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by ANSM, the French medicines agency.[1] Food supplements must be declared to the DGCCRF before sale, and ANSES runs a safety-monitoring scheme for them (nutrivigilance).[2]
[1] ANSM, French medicines agency. Checked 14 Nov 2026.
[2] ANSES. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern omega-3 Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in France.
What doctors and scientists are doing in Omega-3 Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
France · 2 shared keywords
France · 1 shared keyword
France · 1 shared keyword
France · 1 shared keyword
France · 1 shared keyword
France · 1 shared keyword
Digital Health · France
Pharmaceuticals · France
Medical Devices · France
Medical Devices · France
Pharmaceuticals · France
Pharmaceuticals · France